Just started to go through the poster abstracts to see what's particularly interesting for us:
Topics covered in this year's poster session 'Developmental Therapeutics- Immunotherapy', reflecting the currently big questions in Immune Therapy in Melanoma are:
- immune therapies in different combinations
- attempts at profiling by different means to predict which patients are likely to benefit from immune therapy and who will have side effects
- more on side effects related to immune therapies
The poster session will be on Sunday morning, so updates after that!